Naftzger J. Christopher 4
4 · Nabriva Therapeutics plc · Filed Oct 1, 2021
Insider Transaction Report
Form 4
Naftzger J. Christopher
General Counsel and Corp Sec
Transactions
- Award
Share Option
2021-09-30+100,000→ 100,000 totalExercise: $1.19Exp: 2031-09-29→ Ordinary Shares (100,000 underlying)
Footnotes (2)
- [F1]The option was granted on September 30, 2021.
- [F2]The option will vest over a four-year period. Twenty-five percent (25%) of the option will vest on the one (1)-year anniversary of the date of grant, and the remaining seventy-five percent (75%) of the option will vest on an annual pro-rata basis over the remaining vesting period.